Data as of Aug 27
| +0.03 / +0.56%|
The 2 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 22.00, with a high estimate of 35.00 and a low estimate of 9.00. The median estimate represents a +305.16% increase from the last price of 5.43.
The current consensus among 2 polled investment analysts is to Buy stock in Sorrento Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.